IE40361B1 - Pharmaceutical compositions and their preparation - Google Patents

Pharmaceutical compositions and their preparation

Info

Publication number
IE40361B1
IE40361B1 IE86/75A IE8675A IE40361B1 IE 40361 B1 IE40361 B1 IE 40361B1 IE 86/75 A IE86/75 A IE 86/75A IE 8675 A IE8675 A IE 8675A IE 40361 B1 IE40361 B1 IE 40361B1
Authority
IE
Ireland
Prior art keywords
dry powder
bismuth
pharmaceutical compositions
jan
preparation
Prior art date
Application number
IE86/75A
Other versions
IE40361L (en
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of IE40361L publication Critical patent/IE40361L/en
Publication of IE40361B1 publication Critical patent/IE40361B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1478742 Bismuth-containing antacids GISTBROCADES NV 17 Jan 1975 [18 Jan 1974] 2146/75 Heading A5B A solid bismuth-containing powder for use in the treatment of peptic ulcer is prepared by spray-drying an aqueous, colloidal solution comprising bismuth citrate, ammonia and a non-toxic polyhydric alcohol e.g. sucrose or maltose, to produce a dry powder. Pharmaceutical compositions for oral administration comprise (1) the dry powder optionally together with pharmaceutically-acceptable carrier(s) and may be in the form of tablets or capsules or (2) a liquid obtained by dissolving the dry powder in water. The liquid starting material optionally contains pepsin, a colouring agent such as carmine, an alkali metal (e.g. sodium or potassium) hydroxide and a preservative. [GB1478742A]
IE86/75A 1974-01-18 1975-01-17 Pharmaceutical compositions and their preparation IE40361B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IE40361L IE40361L (en) 1975-07-18
IE40361B1 true IE40361B1 (en) 1979-05-09

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
IE86/75A IE40361B1 (en) 1974-01-18 1975-01-17 Pharmaceutical compositions and their preparation

Country Status (18)

Country Link
JP (1) JPS5837284B2 (en)
AT (1) AT349150B (en)
AU (1) AU485660B2 (en)
BE (1) BE824509A (en)
CA (1) CA1040532A (en)
CH (1) CH622947A5 (en)
DE (1) DE2501787A1 (en)
DK (1) DK151770C (en)
ES (1) ES433908A1 (en)
FI (1) FI750113A (en)
FR (1) FR2258177B1 (en)
GB (1) GB1478742A (en)
IE (1) IE40361B1 (en)
IT (1) IT1036072B (en)
LU (1) LU71668A1 (en)
NL (1) NL185130C (en)
SE (1) SE437930B (en)
ZA (1) ZA74385B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
ATE79264T1 (en) * 1985-06-13 1992-08-15 Barry James M D Marshall USE OF BISMUTH IN THE MANUFACTURE OF MEDICATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS CAUSED BY CAMPYLOBACTER POLYRIDIS.
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE318144T1 (en) * 1985-06-13 2006-03-15 Barry James Marshall PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL CONDITIONS, CONTAINING BISMUT AND AN ANTIMICROBIAL AGENT
ES2040307T3 (en) * 1988-10-08 1993-10-16 Dr. R. Pfleger Chemische Fabrik Gmbh PROCEDURE FOR PRODUCING A LIQUID MEDICINAL PREPARATION CONTAINING BISMUTE.
DE3901508C2 (en) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Drug based on a bismuth-containing preparation in solid form
IT1229502B (en) * 1989-01-25 1991-09-03 Euroresearch Srl COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
WO1992001457A1 (en) * 1990-07-20 1992-02-06 Slagel, David Products and processes for the treatment of the alimentary canal
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
MX9703918A (en) 1997-05-28 1998-11-30 J Marshall M D Barry Procedure to prepare a reactive pharmaceutical product to detect gastrointestinal disorder caused by bacteria in superior gastrointestinal tract.
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1900268A1 (en) * 1968-12-23 1969-09-04 Serfontein Willem Jacob Bismuth complex preparation
GB1288789A (en) * 1968-12-23 1972-09-13 Willem Jacob Serfontein Improved bismuth preparations

Also Published As

Publication number Publication date
DE2501787A1 (en) 1975-07-24
BE824509A (en) 1975-07-17
DK12675A (en) 1975-09-15
NL7500552A (en) 1975-07-22
ES433908A1 (en) 1976-11-16
NL185130C (en) 1990-02-01
SE437930B (en) 1985-03-25
ATA31875A (en) 1978-08-15
JPS5837284B2 (en) 1983-08-15
DK151770C (en) 1989-11-06
ZA74385B (en) 1975-08-27
FI750113A (en) 1975-07-19
GB1478742A (en) 1977-07-06
AU485660B2 (en) 1977-07-28
DE2501787C2 (en) 1987-11-12
DK151770B (en) 1988-01-04
AT349150B (en) 1979-03-26
CA1040532A (en) 1978-10-17
FR2258177B1 (en) 1978-07-21
LU71668A1 (en) 1975-06-24
CH622947A5 (en) 1981-05-15
JPS50116623A (en) 1975-09-12
AU7729375A (en) 1976-07-15
FR2258177A1 (en) 1975-08-18
IE40361L (en) 1975-07-18
SE7500501L (en) 1975-07-19
IT1036072B (en) 1979-10-30
NL185130B (en) 1989-09-01

Similar Documents

Publication Publication Date Title
IE40361B1 (en) Pharmaceutical compositions and their preparation
GB1405088A (en) Slow release formulation
JPS5771377A (en) Sweetening agent having low cariogenicity
GB1465347A (en) Composition
SE311208B (en)
GB1530106A (en) Stannous pyrophosphate technetium-99m compositions
GB1344042A (en) Dentrifrices
IE34811L (en) Effervescent tablets and powders
GB1256968A (en)
IT1229502B (en) COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE.
GB1486687A (en) Iron-resin adsorbate
GB1483840A (en) Pharmaceutical preparation containing acetylsalicylic aci
ES404959A1 (en) Aqueous doxycycline compositions
JPS5492618A (en) Poultice
GB1075470A (en) Effervescent tablet
GB1327560A (en) Effervescent pharmaceutical preparations
JPS55108814A (en) Preparation of stable, easily soluble, amorphous magnesium citrate powder for medical use
JPS4814656B1 (en)
GB524756A (en) Medicinal preparations of magnesium hydroxide and precess of obtaining the same
JPS57108012A (en) Preparation of pharmaceutical preparation containing sodium azulenesulfonate
GB1504767A (en) Antibiotic compositions
JPS5345358A (en) Preparation of easily water-dispersible sodium carboxymethyl cellulose
GB1190838A (en) Improvements in or relating to Dental Impression Materials
GB1357813A (en) Effervescent composition for the treatment of heart diseases
GB1192479A (en) A Powderous Composition Comprising 3,5-Dinitro-o-Toluic Acid Amide